Search clinical trials for: selective serotonin reuptake inhibitor

Total 71213 results

Rush University Medical Center

Completed

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Nausea | Vomiting

United States
University of California, San Francisco
National Institute of Mental Health (NIMH); University of California, San Diego and other collaborators

Completed

SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project (SMART-DAPPER)

Trauma | Posttraumatic Stress Disorder | Depression, Unipolar

Kenya
University of Washington
Patient-Centered Outcomes Research Institute; Boston University; Washington State... and other collaborators

Active, not recruiting

Sequenced Treatment Effectiveness for Posttraumatic Stress (STEPS)

PTSD

United States
University of Pennsylvania

Completed

SSRI Effects on Depression and Immunity in HIV/AIDS

Depression | HIV | AIDS

United States
Mayo Clinic
National Cancer Institute (NCI)

Withdrawn

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm

United States
Loyola University
Stanley Medical Research Institute

Completed

Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression

Bipolar Depression

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States, China
University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Completed

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Breast Carcinoma

United States
RAND
National Institute of Mental Health (NIMH); Brigham and Women's Hospital; University... and other collaborators

Active, not recruiting

Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform (IC3D)

Depressive Disorder

Malawi
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Terminated

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

Healthy

United States
Henan Cancer Hospital

Completed

Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

China
Johns Hopkins Bloomberg School of Public Health
Patient-Centered Outcomes Research Institute; National Institute of Mental... and other collaborators

Active, not recruiting

Combining Data Sources to Identify Effect Moderation for Personalized Mental Health

Depressive Disorder, Major

United States
Dr. Nazanin Alavi
Online PsychoTherapy Clinic

Completed

Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions

Generalized Anxiety Disorder

Canada
Pachankis, Yang I., M.D.
First Affiliated Hospital of Chongqing Medical University

Completed

Detoxification From the Lipid Tract

COVID-19 Vaccine Adverse Reaction

China
The Hospital for Sick Children
St. Justine's Hospital; University of Waterloo

Completed

Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants

Breast Feeding

Canada
National Institutes of Health Clinical Center (CC)

Completed

A Clinical Trial of a Gamified Attention Bias Modification Training in Anxious Youth

Anxiety Disorders

United States
Holland Bloorview Kids Rehabilitation Hospital
The Hospital for Sick Children

Enrolling by invitation

Fluoxetine in KCNC1-related Disorder

Rare Diseases | Genetic Disease | KCNC1 Related Disorder

Canada
Indiana University

Terminated

Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes

Depression

United States
Sumitomo Pharma America, Inc.

Completed

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Schizophrenia

United States
Imperial College London
King's College London; University College, London; University of Oxford; University... and other collaborators

Completed

Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia (ACTIONS)

Schizophrenia

United Kingdom
Zhen-Hong Hu

Completed

Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

Adolescent Depression

China
Fundación Pública Andaluza para la gestión de la...

Active, not recruiting

Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis (CLOZ-AID)

Intellectual Disability | Psychosis

Spain
University Hospital, Basel, Switzerland

Completed

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects (SERT-LSD)

Healthy

Switzerland
GlaxoSmithKline

Completed

Concentration-QT Study of Paroxetine in Healthy Adults

Anxiety Disorders

United Kingdom
University of New Mexico
Patient-Centered Outcomes Research Institute; Montana State University; National... and other collaborators

Terminated

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Bipolar Disorder

United States
University of Michigan
National Institute on Aging (NIA)

Active, not recruiting

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Parkinson Disease

United States
JHSPH Center for Clinical Trials
National Institute on Aging (NIA)

Active, not recruiting

Escitalopram for Agitation in Alzheimer's Disease (S-CitAD)

Dementia

United States, Canada
University of Sao Paulo
Columbia University; Amsterdam UMC, location VUmc; University of Stellenbosch; National...

Completed

Predicting Treatment Response in Patients With OCD

Obsessive-Compulsive Disorder

United States, Brazil, India, South Africa
University of Cincinnati
National Institute of Mental Health (NIMH)

Completed

Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth

Depression | Anxiety | Bipolar Disorder

United States
Centre Hospitalier Universitaire Dijon

Terminated

Preliminary Study to Investigate the Effect of rTMS and SSRI Antidepressants on Leukocyte Expression of the C-FOS and DUSP1 Genes in Patients Treated for Depression (TMSFOS)

Depression

France
Xiaomei Shao
First People's Hospital of Hangzhou; The First Affiliated Hospital of Zhejiang... and other collaborators

Completed

The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder

Major Depressive Disorder

China
Susanna Naggie, MD
Vanderbilt University Medical Center; National Center for Advancing Translational...

Completed

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)

Covid19

United States
Charite University, Berlin, Germany

Completed

Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Germany
Minerva Neurosciences

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Negative Symptoms in Schizophrenia

United States
Northwell Health
Takeda

Active, not recruiting

Adjunctive Vortioxetine in Schizophrenia (AVIS)

Schizophrenia | Negative Symptoms

United States
University of Washington
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis (Sleep-HD)

Insomnia | End Stage Renal Disease

United States
Noam Soreni

Withdrawn

Vortioxetine for the Treatment of Hoarding Disorder

Hoarding Disorder

Canada
Sadat City University

Active, not recruiting

The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

Major Depressive Disorder

Egypt
Sadat City University

Active, not recruiting

The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Egypt

Search clinical trials for: selective serotonin reuptake inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations